Metabolic reprogramming in pluripotent induction and cardiac lineage specificatio

多能诱导和心脏谱系特异性中的代谢重编程

• 批准号: 8896042
• 负责人: Clifford D Folmes
• 金额: $ 13.94万
• 依托单位: MAYO CLINIC ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2017-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8896042
• 关键词: Acetyl Coenzyme A; Acids; Address; Advisory Committees; Aging; Anabolism; Area; Award; Back; Biochemical Pathway; Biochemistry; Bioenergetics; Biogenesis; Biological Models; Biology; Cardiac; Cardiac Myocytes; Cardiovascular system; Catabolism; Cell Fate Control; Cell Respiration; Cell physiology; Cells; Cellular Structures; Chronic Disease; Citric Acid Cycle; Clinic; Complement; Complex; Data; Derivation procedure; Development; Disease; Education; Educational Curriculum; Electron Transport; Embryo; Energy Metabolism; Environment; Enzymes; Epigenetic Process; Equilibrium; Event; Fibroblasts; Fostering; Foundations; Functional disorder; Funding; Generations; Genetic; Glycolysis; Goals; Health Professional; Heart; Homeostasis; Knowledge; Lung; Maintenance; Manuscripts; Medicine; Membrane Potentials; Mentors; Metabolic; Metabolic Pathway; Metabolism; Methodology; Mission; Mitochondria; Modeling; Molecular; Molecular Biology; Natural regeneration; Oxidative Phosphorylation; Pathway interactions; Phase; Population; Process; Protocols documentation; Publications; Regenerative Medicine; Rejuvenation; Reporting; Research; Research Infrastructure; Resources; Science; Signal Transduction; Somatic Cell; Specific qualifier value; Staging; Stem cells; Symptoms; Systems Biology; Techniques; Testing; Tissues; Training; Translations; Work; base; cardiogenesis; career; career development; disorder prevention; experience; high throughput technology; improved; induced pluripotent stem cell; innovation; insight; instrument; knowledge base; macromolecule; metabolomics; mitochondrial membrane; new technology; next generation; novel; novel strategies; nuclear reprogramming; pandemic disease; pluripotency; post-doctoral training; prevent; professor; programs; regenerative; regenerative therapy; self-renewal; skills; stem cell biology; stem cell fate; stoichiometry

DESCRIPTION (provided by applicant): Defining the regulators of stem cell fate is critical in deriving lineage-specified populations for tailored regenerative therapy. Beyond established genetic/epigenetic control of cell identity, emerging evidence indicates that the way stem cells use energy and metabolites determine their fate. To maintain tissue regenerative capacity, stem cells must transit between distinct states from active proliferation/self-renewal to differentiatio, each imposing unique bioenergetic demands. To enable transition between distinct states, metabolic plasticity prioritizes biochemical pathways to establish a balance between catabolism, the process of breaking down substrates to produce energy, and anabolism, the process of constructing macromolecules. The overall goal of this proposed research is to understand how plasticity in energy metabolism regulates cell fate decisions and how specific metabolic pathways support stage-specific stem cell function. The K99 phase of this award will focus on defining the specific mitochondrial dependent components and metabolic pathways essential for nuclear reprogramming of somatic cells back to the pluripotent state. This will be accomplished by comparing bona fide induced pluripotent stem cells versus their parental fibroblasts using fundamental mitochondrial biology techniques and high throughput metabolomics/metabolic flux analysis, and validating the impact of identified pathways on nuclear reprogramming using mitochondrial deficient cells and enzyme- specific inhibition. Having developed this expertise in mitochondrial biology and high throughput metabolomics and metabolic flux analysis, the R00 phase of the award will focus on applying these new technologies to a cardiac differentiation protocol that allows isolation of developmental stages during cardiogenesis in order to define the specific mitochondrial complexes and metabolic reprogramming that fuels lineage specification, using cardiac differentiation as a model system. Collectively the K99 and R00, by defining the distinct components of mitochondrial function necessary for initiation of metabolic reprogramming during induction of pluripotency and lineage specification, will fundamentally advance our current knowledge of stem cell metabolism and how it impacts cell fate. Application of this knowledge will enable development of metabolic strategies for generation of tissue-specific cell populations for regenerative therapy, with potential translation to identify new targets based upon energy metabolism to prevent degeneration or elicit rejuvenation in chronic disease. The synergy of the candidate's research experience and outstanding current environment has laid the foundation for the present application in the field of stem cell metabolism and cell fate decisions. His graduate work built upon initial undergraduate training in biochemistry that provided a comprehensive knowledge base in energy metabolism and cardiovascular pathophysiology, which was enhanced with training in stem cell biology and metabolomics profiling during the initial post-doctoral training. The K99 phase of this award will be based at Mayo Clinic, where the core mission focuses on research and education aimed to advance the science of medicine, improve disease prevention and treatment, and prepare next generations of health care professionals. The scientific proposal will benefit from Mayo Clinic's cutting edge technical platforms and core resources, while career development will be facilitated by tailored curriculum established by the mentor, leveraging the career development instruments of Mayo Clinic. The candidate's short-term goals include publication of current and proposed manuscripts on the mitochondrial/metabolic determinants of nuclear reprogramming (K99 phase), establishment of model systems required for the proposed projects and acquisition of comprehensive skill sets to dissect mitochondrial and metabolic function in the setting of decoding stem cell fate decisions. Completion of these goals will facilitate the candidate's long-term career goal of establishing an independent and extramurally funded research program to examine how plasticity in energy metabolism regulates cell fate decisions and how specific metabolic pathways support stage-specific stem cell function (R00 phase). Career development will be fostered through interaction with the mentor, Dr. A. Terzic (Director, Mayo Clinic Center for Regenerative Medicine) and the advisory committee composed of Drs. J. Burnett Jr. (Former Director, Mayo Clinic Heart and Lung Research Center), S. Nair (Director, Mayo Clinic Comprehensive Metabolomics Center), F. Prendergast (Guggenheim Professor of Biochemistry and Molecular Biology), and J. van Deursen (Chair, Department of Biochemistry and Molecular Biology). Emphasis will be placed on acquisition of new skills and methodology, specifically in the areas of mitochondrial biology, metabolomics, metabolic flux analysis and systems biology to complement the current expertise in stem cell biology and NMR based metabolomics. This technical proficiency paired with the conceptual innovation outlined in the scientific proposal provides a launchpad to embark on an independent research career in the emerging domain of stem cell metabolism.

描述（由申请人提供）：定义干细胞命运的调节因子对于衍生用于定制再生治疗的谱系特定群体至关重要。除了已建立的细胞身份遗传/表观遗传控制之外，新出现的证据表明干细胞使用能量和代谢物的方式决定了它们的命运。为了维持组织再生能力，干细胞必须在不同的状态之间转换，从活跃增殖/自我更新到分化，每种状态都提出独特的生物能需求。为了实现不同状态之间的转换，代谢可塑性优先考虑生化途径，以在分解代谢（分解底物产生能量的过程）和合成代谢（构建大分子的过程）之间建立平衡。这项研究的总体目标是了解能量代谢的可塑性如何调节细胞命运决定以及特定的代谢途径如何支持特定阶段的干细胞功能。该奖项的 K99 阶段将重点定义体细胞核重编程回到多能状态所必需的特定线粒体依赖性成分和代谢途径。这将通过使用基本线粒体生物学技术和高通量代谢组学/代谢流分析比较真正诱导的多能干细胞与其亲代成纤维细胞，并使用线粒体缺陷细胞和酶特异性抑制来验证已识别途径对核重编程的影响来实现。凭借在线粒体生物学、高通量代谢组学和代谢流分析方面的专业知识，该奖项的 R00 阶段将重点关注将这些新技术应用于心脏分化方案，该方案允许分离心脏发生过程中的发育阶段，以定义特定的线粒体复合物和代谢重编程，以促进谱系规范，使用心脏分化作为模型系统。 K99 和 R00 共同定义了在诱导多能性和谱系规范过程中启动代谢重编程所需的线粒体功能的不同组成部分，将从根本上推进我们目前对干细胞代谢及其如何影响细胞命运的认识。这些知识的应用将能够开发代谢策略，以生成用于再生治疗的组织特异性细胞群，并有可能转化为基于能量代谢识别新靶点，以防止慢性疾病的退化或引起复兴。候选人的研究经验和当前良好环境的协同作用，为目前在干细胞代谢和细胞命运决定领域的应用奠定了基础。他的研究生工作建立在最初的生物化学本科培训的基础上，提供了能量代谢和心血管病理生理学方面的全面知识库，并在最初的博士后培训期间通过干细胞生物学和代谢组学分析的培训得到了加强。该奖项的 K99 阶段将设在梅奥诊所，其核心任务侧重于研究和教育，旨在推进医学科学、改善疾病预防和治疗，并为下一代医疗保健专业人员做好准备。科学提案将受益于梅奥诊所的尖端技术平台和核心资源，而职业发展将通过导师建立的定制课程、利用梅奥诊所的职业发展工具来促进。候选人的短期目标包括出版关于核重编程（K99阶段）的线粒体/代谢决定因素的当前和拟议的手稿，建立拟议项目所需的模型系统，以及获得在解码干细胞命运决定的背景下剖析线粒体和代谢功能的综合技能。这些目标的完成将促进候选人的长期职业目标，即建立一个独立的、外部资助的研究项目，以研究能量代谢的可塑性如何调节细胞命运决定以及特定的代谢途径如何支持特定阶段的干细胞功能（R00期）。通过与导师 A. Terzic 博士（梅奥诊所再生医学中心主任）以及由 Drs. A. Terzic 博士组成的咨询委员会的互动，将促进职业发展。 J. Burnett Jr.（梅奥诊所心肺研究中心前主任）、S. Nair（梅奥诊所综合代谢组学中心主任）、F. Prendergast（古根海姆生物化学和分子生物学教授）和 J. van Deursen（生物化学和分子生物学系主任）。重点将放在获取新技能和方法，特别是在线粒体生物学、代谢组学、代谢流分析和系统生物学领域，以补充当前干细胞生物学和基于核磁共振的代谢组学方面的专业知识。这种技术熟练程度与科学提案中概述的概念创新相结合，为在干细胞代谢新兴领域开展独立研究生涯提供了一个起点。

项目成果

Energy metabolism in the acquisition and maintenance of stemness.

• DOI: 10.1016/j.semcdb.2016.02.010
• 发表时间: 2016-04
• 期刊: Seminars in cell & developmental biology
• 影响因子: 7.3
• 作者: Folmes CD;Terzic A
• 通讯作者: Terzic A

Metabolic Remodeling during Early Cardiac Lineage Specification of Pluripotent Stem Cells.

• DOI: 10.3390/metabo13101086
• 发表时间: 2023-10-17
• 期刊: Metabolites
• 影响因子: 4.1
• 作者: Bobori SN;Zhu Y;Saarinen A;Liuzzo AJ;Folmes CDL
• 通讯作者: Folmes CDL

Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer.

• DOI: 10.1186/2049-3002-2-13
• 发表时间: 2014
• 期刊: Cancer & metabolism
• 影响因子: 5.9
• 作者: Roy D;Mondal S;Wang C;He X;Khurana A;Giri S;Hoffmann R;Jung DB;Kim SH;Chini EN;Periera JC;Folmes CD;Mariani A;Dowdy SC;Bakkum-Gamez JN;Riska SM;Oberg AL;Karoly ED;Bell LN;Chien J;Shridhar V
• 通讯作者: Shridhar V